Cargando…
浸润性肺腺癌EGFR、ALK基因突变状态与影像学、病理学特征的相关性
BACKGROUND AND OBJECTIVE: At present, the research progress of targeted therapy for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) gene mutations in lung adenocarcinoma is very rapid, which brings new hope for the treatment of advanced lung adenocarcinoma patients. Howe...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976203/ https://www.ncbi.nlm.nih.gov/pubmed/35340157 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.10 |